NCT06237426View on ClinicalTrials.gov

An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Methylone

A course of treatment includes 4 weekly doses of TSND-201.

Trial Locations (9)

20850

Sunstone Medical, Rockville

80209

Mountain View Clinical Research, Denver

84020

Cedar Clinical Research, Inc, Draper

Unknown

La Nua Mental Health Centre, Galway

Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge

Mirabilis Health, Belfast

NHS Greater Glasgow and Clyde, Glasgow

Clerkenwell Health, London

Kings College, London

Sponsors
All Listed Sponsors
lead

Transcend Therapeutics

INDUSTRY